Wellington Management Group LLP Blueprint Medicines Corp Transaction History
Wellington Management Group LLP
- $557 Billion
- Q3 2024
A detailed history of Wellington Management Group LLP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 3,964,610 shares of BPMC stock, worth $358 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,964,610
Previous 3,235,555
22.53%
Holding current value
$358 Million
Previous $349 Million
5.12%
% of portfolio
0.07%
Previous 0.06%
Shares
20 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$604 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$600 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$487 Million0.06% of portfolio
-
State Street Corp Boston, MA2.77MShares$250 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.67MShares$151 Million0.4% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.39B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...